The chemokine receptor type 5 inhibitor maraviroc alleviates sepsis-associated liver injury by regulating MAPK/NF-κB signaling
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025
DOI: 10.1007/s00210-024-03477-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Jun Shao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, 225009, China. Hauptthemen laut MEDLINE: Maraviroc, Sepsis, NF-kappa B, CCR5 Receptor Antagonists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jiangsu Provincial Health Commission Scientific Research Project, YangZhou Municipal Science and Technology Bureau, National Natural Science Foundation of China.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis-related organ damage, as the most intractable problem in intensive care units (ICUs), receives a great deal of attention from healthcare professionals. Sepsis-associated liver injury (SALI) often leads to poor clinical outcomes due to its complex physiological mechanism. In previous studies, chemokine receptor 5 (CCR5) inhibitors were shown to exert unique anti-inflammatory effects. As the therapeutic effect of maraviroc (MVC) on SALI is still unclear, we aimed to explore whether MVC is effective in treating SALI. We established a model of SALI by cecal ligation and puncture (CLP) and intraperitoneally injected 20 mg/kg MVC 2 h after CLP. The results showed that MVC could significantly ameliorate liver injury after CLP. Furthermore, we demonstrated that MVC reduced inflammatory infiltration and apoptosis after SALI. In addition, we found that the function of MVC in reducing inflammation was obtained through the inhibition of the two inflammatory signaling pathways mentioned above. Finally, the JNK agonist AN was chosen for reverse research. As shown by the results, the therapeutic effects of MVC disappeared after AN treatment, indicating that MVC exerted anti-inflammatory and antiapoptotic effects through JNK. Our study revealed that MVC could reduce liver injury after SALI by inhibiting liver inflammation and hepatocyte apoptosis induced by CLP and that MVC exerted diminish inflammatory effects by inhibiting the NF-κB and MAPK signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, 225009, China.
- Department of Center for Cardiac Macrovascular Disease, Northern Jiangsu People's Hospital, Yangzhou, 225001, China.
- Department of Intensive Care Unit, Northern Jiangsu People's Hospital, Yangzhou, 225001, China.
- Department of Neurology, Northern Jiangsu People's Hospital, Yangzhou, 225009, China.
- Department of Neuro Intensive Care Unit, Clinical Medical College of Yangzhou University, Yangzhou, 225001, China.
- Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, 225009, China. hailongyu1982@vip.163.com.
Förderung
- Jiangsu Provincial Health Commission Scientific Research Project
- YangZhou Municipal Science and Technology Bureau
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Chinese Postdoctoral Science Foundation
- Special Fund for Social Key Research and Development Plan of Yangzhou City
Zitieren
APA
Shao, J., Wang, T., Tang, C., Yu, J., Chen, Y., Guo, X., Wang, H., Zhou, L., Zhang, G., Li, Y., Yu, H., & Zheng, R. (2025). The chemokine receptor type 5 inhibitor maraviroc alleviates sepsis-associated liver injury by regulating MAPK/NF-κB signaling. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03477-x
Vancouver
Shao J, Wang T, Tang C, Yu J, Chen Y, Guo X, et al. The chemokine receptor type 5 inhibitor maraviroc alleviates sepsis-associated liver injury by regulating MAPK/NF-κB signaling. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-024-03477-x
BibTeX
@article{Shao2025,
author = {Shao, Jun and Wang, Tianwei and Tang, Chengbin and Yu, Jiangquan and Chen, Ying and Guo, Xin and Wang, Haoran and Zhou, Lulu and Zhang, Guozhong and Li, Yuping and Yu, Hailong and Zheng, Ruiqiang},
title = {The chemokine receptor type 5 inhibitor maraviroc alleviates sepsis-associated liver injury by regulating MAPK/NF-κB signaling},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
doi = {10.1007/s00210-024-03477-x}
}
EUVIMED